Recombinant feline coronavirus S proteins
AssigneePfizer Inc.
InventorsTimothy J. Miller, Albert Paul Reed, Sharon R. Klepfer, Nancy E. Pfeiffer, Brian T. Suiter, Elaine V. Jones
Life of this patent
Estimating the term…
Abstract
The present invention relates to polypeptides and proteins useful in the diagnosis and prevention of disease caused by feline infectious peritonitis virus (FIPV) and feline enteric coronavirus (FECV).
Claims5
A peptide comprising an amino acid sequence selected from the group consisting of amino acid residue numbers 1 to 748, 1 to 223, 1 to 360, 93 to 223, 94 to 223, 97 to 222, 121 to 180, 137 to 151, and 94 to 748, of the amino acid sequence of SEQ ID NO:
- 32.
A peptide consisting of an amino acid sequence selected from the group consisting of amino acid residue numbers 1 to 748, 1 to 223, 1 to 360, 93 to 223, 94 to 223, 97 to 222, 121 to 180, 137 to 151, and 94 to 748, of the amino acid sequence of SEQ ID NO:
- 32.
Dependencies are inferred from the claim text.